Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dabur India Ltd. Interim / Quarterly Report 2020

Jan 30, 2020

59077_rns_2020-01-30_a5c201cf-a583-46ed-ad76-b91770091f33.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Date: January 30, 2020

Scrip Symbol: NSE- DABUR, BSE Scrip Code: 500096

To, Corporate Relation Department BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street, Mumbai- 400001

National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor Plot No. C/l, G Block Bandra - Kurla Complex Bandra (E), Mumbai - 400051

Sub: Investors Communication

Dear Sir,

In compliance ofSEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to enclose a copy of Investors Communication being issued by the company today for your records.

This is for your information and records.

Thanking You,

Yours faithfully,

For Dabur India Limited

Executn/e V P (Finance) and Company Secretary

End: as above

Investor Presentation

Q3 FY20

THE SCIENCE OF

30th January 2020

Agenda

Q3 FY20 – Performance Summary

Q3 FY20 – Consolidated Financials

  • India FMCG business grew by 5.6% in both value and volume
  • International Business grew by 12% on CC basis

  • Consol Material cost reduced by 80 bps to touch 49.9% in Q3 FY20
  • Media expenditure was at 8.6% in Q3 FY20 vs 8.1% in Q3 FY19 – growing by 14.3%
  • Consolidated Operating Margin improved by 70 bps, reaching 20.9% in Q3 FY20

  • Consolidated PAT increased by 8.7%
  • Before exceptional the growth in PAT was 12.8%
  • Consol PAT margin improved by 26 bps to touch 16.9%

Q3 FY20 – Business Overview

  • Contribution of Domestic FMCG reduced from 72.2% to 71.1%
  • International Business contributed 26.1% as compared to 25.0% last year

Agenda

Domestic FMCG Growth – By Verticals – Q3 FY20

Domestic FMCG Business (excluding Foods) grew by 7% in volume terms

Healthcare (HC) – Q3 FY20

Health
Supplements
Digestives OTC Ethicals
Growth % 12.2% 15.9% 5.5% 2.7%
Category
Highlights
Strong double-digit

growth in
Chyawanprash

Dabur's market share in
Chyawanprash
category
increased by ~314 bps
Driven by continued

strong performance of
Hajmola
tablets

Pudin
Hara Lemon Fizz
reported strong double
digit growth
Strong growth in

Honitus
brand

High base growth of
17.7% for OTC
Ethicals' performance

was relatively muted on
account of high base
growth of 17.4% in Q3
FY19
YTD growth of 7.6%

indicative of underlying
growth

Dabur Chyawanprash – Changing Weather TVC

Honitus - Metro Station Branding in

Home & Personal Care (HPC) – Q3 FY20

Oral Care Hair Oils Shampoo & Post
Wash
Home Care Skin & Salon
Growth % 8.5% 0.4% 5.1% 2.5% (0.3%)
Category
Highlights

Red Toothpaste
grew by 9.5%

Babool
Franchise
reported 5%
growth
Lal Dant
Manjan

grew by 10.4%
Market share in

toothpastes
improved by ~30
bps

Growth impacted
by category slow
down

Market share in
hair oils increased
by ~50 bps
Sarson
Amla and

Brahmi Amla
recorded double
digit growth

Vatika
Shampoo
bottles growing in
double digits –
bottles saliency
going up

Market share in
shampoo category
increased by ~60
bps

Strong growth in
Odomos
with gain
in market share
Odonil
Aerosols

reported strong
growth

Skin Care was
relatively muted
on account of
consumption
slowdown and high
base growth of
19.3%

Babool Ayurvedic – New TVC

9

Dabur Red – New TVC Dabur Amla – World's No. 1 Hair Oil

Foods – Q3 FY20

Foods
Growth % (1.7%)
Category
Highlights

As per Nielsen, J&N category declined by 11.6% (in volume) in Q3 due to downtrading to lower priced
alternatives

Excluding Diwali Gift Packs, Real fruit juices grew by ~5%. Diwali Gift Packs were impacted by the shift in
Diwali this year (from Nov in 2018 to Oct in 2019)

Real Activ
grew by 17% on the back of strong growth in Activ
Coconut Water and institutional business
Market share of Real Fruit Juices increased by 530 bps to touch 62.4%
Culinary business under Hommade
brand reported strong double-digit
growth
Real Activ
Coconut Water –
Digital
Real – Diwali Gift Packs Campaign
10
Hommade

Digital Campaign

Agenda

Consumer/ Marketing Initiatives – Healthcare

Consumer/ Marketing Initiatives – Healthcare

Ethicals portfolio – 45 vaid meets covering 2,000 vaids Mega Health Camp for Bhopal Gas Tragedy Victims

Consumer/ Marketing Initiatives – Home & Personal Care

Dabur Amla – Savdhaan Campaign Oxylife – Salon Workshop in Towns

Meswak - New TVC Star Screen Awards Sponsorship by Babool and Fem

Consumer/ Marketing Initiatives – Foods

Agenda

Hajmola Chatpati Hing

Odonil Aerosol - Floral Bliss and Ocean Breeze

Bring home
2 New Exotic Fragrances

Odonil

Floral Bliss | Ocean Breeze

Real Aloe Vera Kiwi

Arshoghani Vati

Agenda

International Business – Q3 FY20

International Business reported CC growth of

12.0%

  • MENA market clocked 10.1% CC growth in this quarter
  • Egypt recorded growth of 17.0%
  • Hobby had a strong quarter, growing by 32.2%
  • Namaste business reported 9.8% growth with a strong

performance in the international business

Nepal business increased by 20.6%

Q3 FY20 Constant Currency Growth %

Product Launches – International Business

Consumer/ Marketing Initiatives – International Business

Consolidated Profit & Loss Statements

figures
All
are in
INR
cr
Q3 FY20 Q3 FY19 Y-o-Y (%) 9M FY20 9M FY19 Y-o-Y (%)
Revenue from operations 2,353.0 2,199.2 7.0% 6,838.2 6,404.9 6.8%
Other Income 74.5 75.3 (1.0%) 229.5 230.1 (0.3%)
Total Income 2,427.4 2,274.5 6.7% 7,067.75 6,634.97 6.5%
Material Cost 1,174.4 1,115.3 5.3% 3,410.6 3,239.7 5.3%
of
%
Revenue
49
9%
50
7%
49
9%
50
6%
Employee expense 244.8 237.6 3.0% 717.7 696.0 3.1%
of
%
Revenue
10
4%
10
8%
10
5%
10
9%
Advertisement and publicity 203.5 178.1 14.3% 549.8 510.6 7.7%
%
of
Revenue
8
6%
8
1%
8
0%
8
0%
Other Expenses 237.4 222.9 6.5% 720.1 676.2 6.5%
of
%
Revenue
10
1%
10
1%
10
5%
10
6%
Operating Profit 492.9 445.4 10.7% 1,440.1 1,282.3 12.3%
%
of
Revenue
20
9%
20
3%
21
1%
20
0%
EBITDA 567.4 520.6 9.0% 1,669.6 1,512.5 10.4%
of
%
Revenue
24
1%
23
7%
24
4%
23
6%
Finance Costs 10.5 16.7 (37.4%) 41.0 47.2 (13.2%)
Depreciation & Amortization 54.4 44.9 21.3% 161.6 130.7 23.7%
Profit before exceptional items, tax and share
of profit/(loss) from joint venture
502.5 459.1 9.5% 1,467.0 1,334.6 9.9%
%
of
Revenue
21
4%
20
9%
21
5%
20
8%
Share of profit / (loss) of joint venture (0.2) 0.5 (128.8%) 0.4 1.0 (62.4%)
Exceptional item(s) 20.0 0.0 n.a. 80.0 0.0 n.a.
Tax Expenses 83.5 92.4 (9.6%) 221.1 260.8 (15.2%)
Net profit after tax and after share of
profit/(loss) from joint venture
398.9 367.2 8.6% 1,166.3 1,074.8 8.5%
of
%
Revenue
17
0%
16
7%
17
1%
16
8%
Non controlling interest 1.2 1.2 0.9% 2.5 2.9 (11.5%)
Net profit for the period/year 397.7 366.1 8.7% 1,163.8 1,071.9 8.6%
of
%
Revenue
16
9%
16
6%
17
0%
16
7%

Standalone Profit & Loss Statements

figures
All
are in
INR
cr
Q3 FY20 Q3 FY19 Y-o-Y (%) 9M FY20 9M FY19 Y-o-Y (%)
Revenue from operations 1,748.2 1,664.5 5.0% 4,988.6 4,674.8 6.7%
Other Income 67.3 67.4 (0.1%) 209.9 211.7 (0.9%)
Total Income 1,815.4 1,731.8 4.8% 5,198.50 4,886.45 6.4%
Material Cost 895.1 863.9 3.6% 2,568.10 2,436.99 5.4%
of
%
Revenue
51
2%
51
9%
51
5%
52
1%
Employee expense 149.7 147.9 1.2% 444.7 429.1 3.6%
%
of
Revenue
8
6%
8
9%
8
9%
9
2%
Advertisement and publicity 166.3 147.0 13.1% 445.1 413.8 7.6%
of
%
Revenue
9
5%
8
8%
8
9%
8
9%
Other Expenses 145.5 140.2 3.8% 448.1 421.3 6.4%
%
of
Revenue
8
3%
8
4%
9
0%
9
0%
Operating Profit 391.6 365.5 7.1% 1,082.7 973.5 11.2%
of
%
Revenue
22
4%
22
0%
21
7%
20
8%
EBITDA 458.8 432.9 6.0% 1,292.5 1,185.2 9.1%
of
%
Revenue
26
2%
26
0%
25
9%
25
4%
Finance Costs 4.7 9.5 (51.3%) 16.6 23.5 (29.2%)
Depreciation & Amortization 32.6 28.0 16.7% 96.8 80.2 20.7%
Profit before exceptional items, tax and share
of profit/(loss) from joint venture
421.5 395.4 6.6% 1,179.14 1,081.52 9.0%
of
%
Revenue
24
1%
23
8%
23
6%
23
1%
Exceptional item(s) 20.0 0.0 n.a. 80.0 0.0 n.a.
Tax Expenses 71.5 83.2 (14.1%) 185.8 231.5 (19.8%)
Net profit for the period/year 330.0 312.1 5.7% 913.3 850.0 7.5%
of
%
Revenue
18
9%
18
8%
18
3%
18
2%

Get Fast Relief with Dabur Honitus.

As per AC Nielsen RMS Dec'2018 data

For more information & updates, visit : http://www.dabur.com/in/en-us/investor